NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.38 0.00 (0.00%) GOLD FUTURES
2,324.30 +0.10 (+0.00%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,414.65 -361.68 (-0.71%)
Nanophase Technologies Corporation (NANX)
| Previous close | 1.4700 |
| Open | 1.4500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.2400 - 1.4800 |
| 52-week range | 0.3200 - 1.4900 |
| Volume | |
| Avg. volume | 12,875 |
| Market cap | 81.181M |
| Beta (5Y monthly) | 1.49 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Nanophase Reports Record First Quarter Results
— Delivered $9.9 Million in Q1 Revenue— $0.9 Million in Profit— BASF Litigation Resolved ROMEOVILLE, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced financial results for the first quarter ended March 31, 2024. Jess Jankowski
- GlobeNewswire
Nanophase Technologies Announces First Quarter 2024 Financial Release and Conference Call Details
Romeoville, Ill., April 19, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced the Company will disseminate a financial news release for the First Quarter 2024 after market close on Tuesday, April 23, 2024, with an investor conference call to f
- GlobeNewswire
Nanophase Announces Successful Litigation Settlement
ROMEOVILLE, Ill., April 11, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — announced today that it has agreed to a successful and amicable resolution of all ongoing litigation with BASF. The parties have executed a Settlement Agreement, an amendment to the
